BBIO
BridgeBio Pharma Inc.
$61.98
-$0.66(-1.05%)
51
Overall
40
Value
63
Tech
50
Quality
Market Cap
$12.33B
Volume
2.14M
52W Range
$21.72 - $69.48
Target Price
$81.26
EPS Estimates Overview
| Current Quarter | $-0.73 | Next Quarter | $-0.65 |
| Current Year | $-3.44 | Next Year | $-1.86 |
| QoQ Growth | +11.0% | YoY Growth | +45.9% |
| 3Y EPS CAGR | +9.6% | Target Price | $81.26 |
| Consensus | Buy | Upside | +31.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BBIO | $61.98 | -1.1% | 2.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |